Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea
· Delayed Price · Currency is KRW 9,710.00
-410.00 (-4.05%)
At close: Dec 5, 2025
Tdspharm Revenue
Tdspharm had revenue of 8.08B KRW in the quarter ending September 30, 2025, with 25.01% growth. This brings the company's revenue in the last twelve months to 24.56B, down -20.27% year-over-year. In the year 2024, Tdspharm had annual revenue of 27.52B, down -8.42%.
Revenue (ttm)
24.56B
Revenue Growth
-20.27%
P/S Ratio
2.19
Revenue / Employee
n/a
Employees
n/a
Market Cap
53.70B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |